TSS
LIMN

Two Sigma Securities’s Liminatus Pharma LIMN Stock Holding History

Two Sigma Securities’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79K Buy
22,039
+10,164
+86% +$5.42K ﹤0.01% 1532
2025
Q4 		$7.24K Buy
+11,875
New +$13.2K ﹤0.01% 1320

Other funds holding LIMN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's LIMN Position: Q1 2026 in Review

Two Sigma Securities increased its Liminatus Pharma (LIMN) stake by 86% in Q1 2026, buying an estimated $5.42K and bringing the position to 22,039 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Two Sigma Securities first reported a position in LIMN in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.24K in Q4 2025. 15 funds tracked by Wall St. Rank hold LIMN as of Q1 2026.

  • Two Sigma Securities held 22,039 shares of Liminatus Pharma worth $3.79K as of Q1 2026.
  • Two Sigma Securities bought 10,164 Liminatus Pharma shares in Q1 2026, an estimated $5.42K.
  • Liminatus Pharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1532 holding.
  • Two Sigma Securities first reported a position in Liminatus Pharma in Q4 2025 and has held it in 2 quarters since.
  • Two Sigma Securities's Liminatus Pharma position peaked at $7.24K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Liminatus Pharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.